Bolt Technology Corp.

Bolt Technology Corp. is an AMEX listed security that has been trading in a range between $11.00 and $59.35 over the past year. With 5,614,890 shares outstanding, a recent price of $52.73 gives a total market capitalization of $316,118,303. While there are certainly larger companies, Bolt Technology Corp. has definitely earned its place in the pack. Last year, Bolt Technology Corp. created $1.56 in earnings for every share outstanding.

Bolt Technology Corp. is currently priced by the market at 36.20 times last year’s earnings. Many trading multiples around the world are quite attractive these days, but don’t be fooled. A Price to Earnings ratio of 0 simply means that the security didn’t make any money last year.

With a share price over $50 a share and earnings per share in excess of $1 a share, Bolt Technology Corp. could be an interesting value proposition.

IMS Health Inc.

IMS Health Inc. is among the world’s largest Health Care Technology sector businesses in the world.  IMS Health Inc.’s employees generate $283.0M in profits on $2.023B of revenue.  Global output in the Health Care Technology business will likely rise substantially over the next 10 years.  Long-term economic growth may lift all boats, but IMS Health Inc. is determined to remain a market leader.  Sectoral leadership in the Health Care Technology segment takes dedication and consistency, but management seeks out-sized growth.

IMS Health Inc.’s ticker symbol RX has recently been trading near $32.34 a share.  The IMS Health Inc. corporate headquarters in Norwalk CT predicts Health Care Technology profits will satisfy shareholders in search of risk-appropriate returns.

The significance of market volume is sometimes ignored, but with a total market capitalization of $6.346B ensures sufficient liquidity.  With a beta of 0.72, the company is less volatile than the market as a whole.  When the average equity moves lower, IMS Health Inc. moves less aggressively.

Applera Corp-Applied Biosystems Group

Applera Corp-Applied Biosystems Group is among the world’s largest Life Sciences Tools and Services sector businesses in the world. Applera Corp-Applied Biosystems Group’s employees generate $152.1M in profits on $2.059B of revenue. Global output in the Life Sciences Tools and Services business will likely rise substantially over the next 10 years. Long-term economic growth may lift all boats, but Applera Corp-Applied Biosystems Group is determined to remain a market leader. Sectoral leadership in the Life Sciences Tools and Services segment takes dedication and consistency, but management seeks out-sized growth.

Applera Corp-Applied Biosystems Group’s ticker symbol ABI has recently been trading near $30.52 a share. The Applera Corp-Applied Biosystems Group corporate headquarters in Norwalk, CT predicts Life Sciences Tools and Services profits will satisfy shareholders in search of risk-appropriate returns.

The significance of market volume is sometimes ignored, but with a total market capitalization of $5.645B ensures sufficient liquidity. With a beta of 1.13, the company is more volatile than the market as a whole. When the average equity moves higher, Applera Corp-Applied Biosystems Group moves more aggressively.